8-810:
Transfusion of plasma, plasma components and infusion of volume replacement fluids: Transfusion of plasma components and genetically engineered plasma proteins
- 8-810.6 Recombinant activated factor VII
- 8-810.7 Plasma-derived factor VII
- 8-810.8 Recombinant factor VIII
- 8-810.9 Plasma-derived factor VIII
- 8-810.a Recombinant factor IX
- 8-810.b Plasma-derived factor IX
- 8-810.c FEIBA – prothrombin complex with factor eight inhibitor bypass activity
- 8-810.d Von Willebrand factor
- 8-810.e Factor XIII
- 8-810.g Antithrombin III
- 8-810.h C1 esterase inhibitor
- 8-810.j Fibrinogen concentrate
- 8-810.q Human immunoglobulin, hepatitis B surface antigen-specific (HBsAg)
- 8-810.s Human immunoglobulin, cytomegalovirus-specific (CMV)
- 8-810.t Human immunoglobulin, varicella-zoster virus-specific (VZV)
- 8-810.w Human immunoglobulin, polyvalent
- 8-810.x Other
- 8-810.y Unspecified
Source
Provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).